COVID-19 vaccination in advanced skin cancer patients receiving systemic anticancer treatment: A prospective singlecenter study investigating seroconversion rates

BACKGROUND: COVID-19 vaccination reduces risk of SARS-CoV-2 infection, COVID-19 severity and death. However, the rate of seroconversion after COVID-19 vaccination in cancer patients requiring systemic anticancer treatment is poorly investigated. The aim of the present study was to determine the rate...

Descripción completa

Detalles Bibliográficos
Autores principales: Lodde, Georg C., Fiedler, Melanie, Dittmer, Ulf, Placke, Jan-Malte, Jansen, Philipp, Becker, Jürgen C., Zimmer, Lisa, Livingstone, Elisabeth, Schadendorf, Dirk, Sondermann, Wiebke, Ugurel, Selma
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9448664/
https://www.ncbi.nlm.nih.gov/pubmed/36091146
http://dx.doi.org/10.3389/fonc.2022.879876

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9448664/
https://www.ncbi.nlm.nih.gov/pubmed/36091146
http://dx.doi.org/10.3389/fonc.2022.879876

Ejemplares similares